2656 — 160 Health International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapMomentum Trap

Annual income statement for 160 Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Revenue
Total Revenue	526	629	621
Cost of Revenue
Gross Profit	118	137	160
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	605	728	725
Operating Profit	-79.2	-99.5	-105
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-119	-111	-107
Provision for Income Taxes
Net Income After Taxes	-119	-111	-108
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-111	-109	-108
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-111	-109	-108
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.329	-0.3	-0.288